Statistics

Total Visits

Views
DO CHRONIC MYELOID LEUKEMIA PATIENTS WITH LATE "WARNING" RESPONSES BENEFIT FROM SWITCHING THERAPY TO A SECOND GENERATION TYROSINE KINASE INHIBITOR?15

Select a period of time:

Number of views in the range

Views
DO CHRONIC MYELOID LEUKEMIA PATIENTS WITH LATE "WARNING" RESPONSES BENEFIT FROM SWITCHING THERAPY TO A SECOND GENERATION TYROSINE KINASE INHIBITOR?12

Views

Views
May 20243
June 20241
July 20241
August 20245
September 20241
October 20240
November 20241
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States12
 

Top cities views

Views
Chicago3
Fort Worth2
Ashburn1
DeKalb1